Carlos Munoz-Zuluaga

51PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursPredictive and prognostic markersNeurosciences not elsewhere classifiedCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Mar 02, 2026
Patient-Reported Financial Toxicity of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Vladislav Kovalik, Armando Sardi, Luis Felipe Falla-Zuniga

|Sep 09, 2025
Recurrence Incidence and Optimal Surveillance After Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Mucinous Appendix Cancer.

V Kovalik, A Sardi, M C King

|Aug 26, 2025
Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgery.

Luis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King

|Jul 01, 2025
The Effect of Prior Nondefinitive Surgery on Perioperative Outcomes and Survival in Mucinous Appendix Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Sergei Iugai, Vadim Gushchin, Mary C King

|May 10, 2025
Utility of Left Lateral Liver Lobectomy in Removing Retrohepatic Lesions During Cytoreductive Surgery for Low-Grade Mucinous Carcinoma Peritonei.

Andrei Nikiforchin, Armando Sardi, Mary Caitlin King

|May 05, 2025
Presentation Patterns and Treatment Outcomes in Appendix Cancer Patients Traveling to a High-Volume Peritoneal Surface Malignancy Center.

Vladislav Kovalik, Armando Sardi, Mary Caitlin King

Pageof 9

Frequent Collaborators

21 joint publications

Mary Caitlin King

21 joint publications

Vadim Gushchin

10 joint publications

Andrei Nikiforchin

9 joint publications

Mary Caitlin King